Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acebutolol vs propranolol for proliferative infantile hemangiomas
2011-004145-41Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Montpellier
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acebutolol and propranolol in Capillary Haemangioma (2 arms), sponsored by Centre Hospitalier Universitaire de Montpellier. Primary endpoint: Change in hemangioma volume at 90 days. Started Jan 2012; status: active.
02
Drugs
acebutololpropranolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on 2011-004145-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004145-41.